PAVmed Inc.
PAVM
$0.72
-$0.04-5.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -99.00% | 1.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -99.00% | 1.74% | |||
| Cost of Revenue | -96.52% | -17.11% | |||
| Gross Profit | 90.13% | 43.96% | |||
| SG&A Expenses | -54.62% | -14.95% | |||
| Depreciation & Amortization | -100.00% | -21.90% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -58.67% | -14.25% | |||
| Operating Income | 55.20% | 15.39% | |||
| Income Before Tax | -98.12% | 507.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -98.12% | 507.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -92.16% | -9.76% | |||
| Net Income | -97.78% | 694.80% | |||
| EBIT | 55.20% | 15.39% | |||
| EBITDA | 54.87% | 15.24% | |||
| EPS Basic | -98.07% | 639.36% | |||
| Normalized Basic EPS | 81.06% | 36.13% | |||
| EPS Diluted | -100.85% | 220.88% | |||
| Normalized Diluted EPS | 93.05% | 85.64% | |||
| Average Basic Shares Outstanding | 8.22% | 9.32% | |||
| Average Diluted Shares Outstanding | 196.70% | 385.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||